GlassScriptPhysician profile
Jugal Dalal
NPI 1386006914
$14,253.56
in general payments reported to CMS, 2019-2025
18 companies · $2,467 in 2025
The $2,467 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $10.11 · 2021: $798 · 2022: $2,817 · 2023: $5,331 · 2024: $2,830 · 2025: $2,467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,829 · Travel and Lodging: $3,784 · Education: $15.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,829.29 |
| Travel and Lodging | $3,784.28 |
| Education | $15.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,050.74 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $4,231.21 | 2020-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Pain Management |
| Relievant Medsystems, INC. | $1,325.21 | 2023 | Intracept |
| Abbott Laboratories | $984.94 | 2023-2025 | Eterna, Proclaim, Octrode |
| Spr Therapeutics, INC | $707.53 | 2022-2025 | Sprint Pns System |
| Forte Bio-Pharma LLC | $452.68 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Nevro Corp. | $381.92 | 2021-2024 | Senza |
| Globus Medical, INC. | $328.22 | 2025 | Senza, Omnia |
| Saluda Medical Americas, INC. | $228.86 | 2024-2025 | Evoke |
| Vertos Medical, INC. | $136.72 | 2024 | Mild Device Kit |
| Mml US, INC. | $109.12 | 2023-2024 | Reactiv8 |
| Scilex Pharmaceuticals INC. | $100.68 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $57.58 | 2025 | Horizant |
| Nalu Medical, INC. | $54.82 | 2023-2025 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $42.90 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $30.75 | 2021 | |
| Virtus Pharmaceuticals LLC | $14.86 | 2025 | Levorphanol Tartrate |
| Avanos Medical | $14.82 | 2025 | Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jugal Dalal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.